DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $554,579 | -2.2% | 61,895 | +22.8% | 0.00% | – |
Q2 2023 | $566,854 | +1007.0% | 50,387 | +1033.6% | 0.00% | – |
Q1 2023 | $51,206 | -56.6% | 4,445 | -56.3% | 0.00% | – |
Q4 2022 | $117,859 | -92.7% | 10,169 | -92.0% | 0.00% | -100.0% |
Q3 2022 | $1,608,000 | -41.9% | 126,578 | -68.6% | 0.00% | -50.0% |
Q2 2022 | $2,766,000 | +3741.7% | 402,656 | +5322.2% | 0.00% | – |
Q1 2022 | $72,000 | -56.4% | 7,426 | -46.6% | 0.00% | – |
Q4 2021 | $165,000 | +166.1% | 13,919 | +267.2% | 0.00% | – |
Q3 2021 | $62,000 | +55.0% | 3,791 | +101.9% | 0.00% | – |
Q2 2021 | $40,000 | +135.3% | 1,878 | +75.8% | 0.00% | – |
Q1 2021 | $17,000 | -69.6% | 1,068 | -59.8% | 0.00% | – |
Q4 2020 | $56,000 | – | 2,659 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |